Compound ID | 960
Syn2190
Synonym(s): Syn-2190 | Syn 2190
Class: Beta-lactamase inhibitor
| Agent Type: | Semisynthetic; Small molecule; Direct acting; Antibiotic adjuvant; |
| Spectrum of activity: | Gram-negative |
| Target Pathogen: | Active against Pseudomonas aeruginosa |
| Combined with other compounds: | Test in combination with ceftazidime, cefpirome, cefozopran and cefepime |
| Description: | A monobactam; tests in combination with ceftazidime, cefpirome, cefozopran and cefepime resulted in lowered MICs than antbiotics alone |
| Institute where first reported: | SynPhar Laboratories (NAEJA Pharmaceutical, Canada) |
| Year first mentioned: | 1997 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/272855635 |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.